	Soluble CD163 as a Biomarker of Liver Fibrosis and Inflammation in Liver Transplant Recipients. Clin Transplant Lauridsen EHE, Gantzel RH, Suarez-Zdunek MA, Nielsen MB, Rasmussen A, Nielsen SD, Grønbæk H, Villadsen GE. PMID: 41615265 [PubMed - indexed for MEDLINE]
	Capillary microvascular function in patients with liver cirrhosis: a nailfold video-capillaroscopy study. Ann Gastroenterol Papagiouvanni I, Theodorakopoulou M, Protopapas AA, Dimitroulas T, Doumas M, Sinakos E, Sarafidis P, Goulis I. PMID: 41612992 [PubMed]
	Correction: Patient perceived quality of cirrhosis care- adjunctive nurse-based care versus standard medical care: a pragmatic multicentre randomised controlled study. BMC Nurs Hjorth M, Svanberg A, LoMartire R, Kaminsky E, Rorsman F. PMID: 41612337 [PubMed]
	Rifaximin reduces rehospitalization risk in patients with cirrhosis and overt hepatic encephalopathy. Hepatol Commun Jesudian AB, Gagnon-Sanschagrin P, Bungay R, Easson K, Bellefleur R, Guérin A, Shah SK, Olujohungbe O. PMID: 41610161 [PubMed - indexed for MEDLINE]
	Hyperammonemia predicts the development of liver-related events in a prospective cohort of stable cirrhosis patients and the external validation of the AMMON-OHE score. Hepatol Commun Pooi Ling L, Koh XH, Lim Yan Zheng D, Tan CK, Wong YJ, Tan Yi Lyn J, Kwek A, Leong AT, De Roza M, Keat TH, Ho C, Chang J, Raj P, Kumar R. PMID: 41610149 [PubMed - indexed for MEDLINE]
	A liver function test pathway significantly increases the early detection of chronic liver disease and cirrhosis. Hepatol Commun Gao J, Ahmed H, Cannings-John R, Akbari A, Davies A, Pembroke TPI. PMID: 41610148 [PubMed - indexed for MEDLINE]
	The impact of oral health-related quality of life and country-level context on patients with cirrhosis: a cross-sectional study. Rev Esp Enferm Dig Medina JB, Dos Santos Matioli A, Haye Biazevic MG, Michel-Crosato E, Pérez-Jardón A, Franco JB, Pérez-Sayáns M, López Ortega K. PMID: 41608840 [PubMed - as supplied by publisher]
	Overlap between body composition abnormalities and sex-specific prognostication in decompensated cirrhosis. Front Nutr Yang J, Song Y, Liu Q, Sun C. PMID: 41608517 [PubMed]
	The Emerging Challenge of Non-Cirrhotic MASLD-Related Hepatocellular Carcinoma: Etiology, Immunopathology, and Precision Oncology. Liver Cancer Liu Y. PMID: 41607858 [PubMed - as supplied by publisher]
	Development of a nomogram model based on spleen volume change to predict high-risk esophageal varices in patients with liver cirrhosis. Front Surg Li ZJ, Chen J, Li L, Zhan YT. PMID: 41607378 [PubMed]
	QuantiFERON-Monitor as Prognostic Marker of Mortality in Patients with Decompensated Cirrhosis: a Prospective Cohort Study. Clin Res Hepatol Gastroenterol Dongier A, Louis E, Loly JP, Dandoy P, Warling O, Vijverman A, Delwaide J. PMID: 41605414 [PubMed - as supplied by publisher]
	Comparing nurse-assisted outpatient follow-up with standard care among patients with decompensated liver cirrhosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol Guo J, Wang Y, Liu X, Wang X. PMID: 41604551 [PubMed - as supplied by publisher]
	Meta-analysis of reference values of cardiorespiratory fitness and impact of interventions in patients with cirrhosis. Expert Rev Gastroenterol Hepatol Couret A, Rannou F, Pereira B, Duclos M, King JA, Dharancy S, Nevière R, Weil-Verhoeven D, Ennequin G, Abergel A. PMID: 41603324 [PubMed - as supplied by publisher]
	IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell Injury. Liver Int Zhou X, Shao S, Yang D, Cheng Z, Tanaka T, Leung PSC, Tsuneyama K, Ansari AA, Ridgway WM, Invernizzi P, Bowlus CL, Gershwin ME, Zhang W. PMID: 41603281 [PubMed - indexed for MEDLINE]
	Construction of a Bayesian network-based risk prediction model for hepatocellular carcinoma in cirrhotic patients. Front Oncol Ma N, Song J, Yang Y. PMID: 41602421 [PubMed]
	Comparison of inflammatory markers and microflora in cirrhotic patients with portal vein thrombosis: a retrospective study. Front Med (Lausanne) Sun Y, Wang C, Wang D, Hou H, Zhang J, Li Y, Bai Y. PMID: 41601763 [PubMed]
	Coagulation Abnormalities in Liver Cirrhosis: Diagnostic and Therapeutic Approaches. Medicina (Kaunas) Bozic D, Babic A, Olic I, Lalovac M, Mijic M, Madir A, Podrug K, Mestrovic A. PMID: 41597390 [PubMed - indexed for MEDLINE]
	Assessment of Liver Fibrosis Stage and Cirrhosis Regression After Long-Term Follow-Up Following Sustained Virological Response. Diagnostics (Basel) Canillas L, Naranjo D, Broquetas T, Sánchez J, Pocurull A, Garrido E, Fernández R, Forns X, Carrión JA. PMID: 41594255 [PubMed]
	(68)Ga-FAPI-04 PET/CT in the Diagnosis of Hepatocellular Carcinoma Associated with Cirrhosis: Diagnostic Value, Correlation Between PET Parameters of the Tumor and Its Size, and PIVKA-II Levels. Diagnostics (Basel) Zholdybay Z, Zhakenova Z, Issamatov B, Gabdullina M, Filippenko Y, Yessentayeva S, Alisherov G, Amankulov J, Fakhradiyev I. PMID: 41594225 [PubMed]
	Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis-Related Fibrosis: Therapeutic Options and Approaches to Treatment. Annu Rev Med Tincopa MA, Speliotes EK, Valenti L, Loomba R. PMID: 41592926 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 37860

Page 1 of 1893



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy